ArticleScientific reports2025
Evaluation of the antibacterial potential in shoot and root extracts of Eryngium campestre with emphasis on Egyptian ecotype.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Potent Therapeutic Insights FromFood science & nutrition · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The antibacterial potential of Egyptian Eryngium campestre (E. campestre) was evaluated by investigating the growth inhibition of ethanolic shoot and root crude extracts and their solvent fractions against nine bacterial species, revealing a selective differential effect. Phytochemical screening of crude extracts identified the presence of flavonoids, alkaloids, tannins, saponins, phenols, terpenoids, steroids, and coumarins, suggesting their potential contribution to the observed antibacterial effects. Notably, the ethyl acetate fraction of the shoot and the petroleum ether fraction of the root demonstrated the highest activity, inhibiting the growth of all tested bacteria. Comparative analysis with other ecotypes highlighted variations in their antibacterial potency. These findings position the Egyptian E. campestre ecotype as a promising source for pharmaceutical industry, particularly for developing biocontrol agents against bacterial infectious diseases, including multidrug-resistant strains.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.